| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135478 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/22/2006 | US20060135376 Premium wear-resistant lubricant containing non-ionic ashless anti-wear additives |
| 06/21/2006 | EP1671941A1 Substituted benzanilide compound and pest control agent |
| 06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
| 06/21/2006 | EP1670753A2 Modafinil compositions |
| 06/21/2006 | EP1670752A1 2-cyanobenzenesulfonamides for combating animal pests |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1173417B1 Process and apparatus for making ultra-pure dmso |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791571A Modafinil synthesis process. |
| 06/20/2006 | US7064214 Reacting an amino-containing sulfinic acid with a metal hydrocarbon or halometal hydrocarbon to obtain a sterically pure product; pantoprazole; omeproazole; lansproazole; rabeproazoe; gastrointestinal disorders |
| 06/20/2006 | US7064124 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7063928 An apparatus having an organophotoreceptor in the form of a flexible belt threaded around support rollers and having a charge transfer compound comprising a fluorenone hydrazone including other functional groups and phenyl and heteraryl rings;used with liquid toner; durability |
| 06/20/2006 | CA2162706C 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | US20060128812 Esterification of 2-[(diphenylmethyl)thio]acetic acid with an acyclic alcohol under reflux in the presence of an acid catalyst; amidation with ammonia; further oxidation with hydrogen peroxide produces Modafinil; central nervous system stimulant; narcolepsy |
| 06/15/2006 | US20060128767 Methods of preparing sulfinamides and sulfoxides |
| 06/15/2006 | US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/15/2006 | US20060128662 Novel compounds for treatment of obesity |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | EP1669347A1 Process for the preparation of 3-¬(4-fluorophenyl) sulfonyl|-2-hydroxy-2-methyl propionic acid |
| 06/14/2006 | EP1667964A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1102742B1 Compounds and compositions for delivering active agents |
| 06/14/2006 | CN1788009A Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | CN1784381A Method for crystallizing guanidinium salts |
| 06/07/2006 | CN1781905A Method for producing dihydroxydiphenylsulfone isomer mixture |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1258526C Substituted beta-diketones and their use |
| 06/07/2006 | CN1258525C Process for purifying coenzyme Q10 intermediate |
| 06/06/2006 | US7057069 production of modafinil by reacting benzhydrol, thiourea and hydrobromic acid with a base potassium carbonate salt, then hydrolyzing with poatssium hydroxide and chloroacetamide; useful in treatment of narcolepsy and other sleep disorders; commercial scale |
| 06/06/2006 | US7057068 Process for the preparation of modafinil |
| 06/06/2006 | US7057067 Reacting a benzoic acid with a halogenating agent in presence of palladium catalyst to form halogenated benzoic acid or derivatives |
| 06/06/2006 | US7056953 (E)-styryl sulfone anticancer agents |
| 06/06/2006 | US7056640 Improved resolution, improved focus latitude, and minimized line width variation or shape degradation even on long-term PED. |
| 06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2006 | WO2006012603A3 Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
| 06/01/2006 | US20060116361 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 05/31/2006 | EP1660481A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 05/31/2006 | EP1660439A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 05/31/2006 | EP1660431A2 Phenoxyacetic acid derivatives |
| 05/31/2006 | EP1660428A1 Ppar modulators |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660195A2 Methods using fluorosulfones for extinguishing and preventing fire |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053123 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | CA2106613C Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 05/26/2006 | CA2587040A1 Prodrugs of (2r)-2-propyloctanoic acid for treatment of stroke |
| 05/25/2006 | US20060111585 Title of the invention n-cyclohexylaminocarbonyl benzensulfonmide derivatives |
| 05/25/2006 | US20060111445 Novel carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 05/25/2006 | US20060111430 2,3,4-substituted cyclopentanones as therapeutic agents |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | CN1777812A Modulators of the G protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775749A Benzyl iso-octyl sulfoxide, and its preparing method, and method for extracting and separating palladium-platinum using same |
| 05/23/2006 | US7049455 Process for producing shogaols and intermediates for the synthesis thereof |
| 05/23/2006 | US7049317 CCR-3 receptor antagonists |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/23/2006 | CA2152289C Process for preparing aromatic olefins using palladacycle catalysis |
| 05/18/2006 | WO2005097739A3 Nucleophilic substitution reactions of difluoromethyl phenyl sulfone with alkyl halides leading to the facile synthesis of terminal 1,1-difluoro-1-alkenes and difluoromethylalkanes |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | CN1772749A Fungicides for the control of take-all disease of plants |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045649 compounds are suitable, for example, for use as anorectics |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045518 Compounds for treatment of AIDS with enzyme inhibitors |
| 05/16/2006 | CA2291650C Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 05/11/2006 | WO2006048330A1 11βετα-hsd1 inhibitors |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 05/10/2006 | EP1655283A1 11beta-HSD1 Inhibitors |
| 05/10/2006 | EP1654223A1 Fluorosulfone compounds |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | CN1769318A Polymeric resin compounds and their preparation |
| 05/10/2006 | CN1255377C Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate |
| 05/09/2006 | US7041844 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
| 05/09/2006 | US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | CA2163336C Ionic conducting material having good anticorrosive properties |
| 05/09/2006 | CA2125105C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | WO2006012227A3 Amido compounds and their use as pharmaceuticals |
| 05/04/2006 | WO2005105718A3 Process for the production of cyclic diketones |
| 05/04/2006 | US20060094788 Prostaglandin derivatives |